Clinical and pharmacological phase I evaluation of ExherinTM (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours
(Q62944928)
scientific article published on 03 February 2009
scientific article published on 03 February 2009
Language:
Current Data About
Clinical and pharmacological phase I evaluation of ExherinTM (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours
other details
| description | scientific article published on 03 February 2009 |
External Links
| (P356) |
10.1093/ANNONC/MDN695
|
| (P698) |
19190075
|